M. Scott Salka
Vorstandsvorsitzender bei Vesper Biologics, Inc.
Aktive Positionen von M. Scott Salka
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
| Vesper Biologics, Inc. | Vorstandsvorsitzender | - | - |
| CendR, Inc. | Vorstandsvorsitzender | - | - |
| San Diego State University | Direktor/Vorstandsmitglied | 01.01.2009 | - |
BIOCOM
 BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 01.01.2007 | - |
| SDSU College of Business Administration | Direktor/Vorstandsmitglied | - | - |
Arog Pharmaceuticals, Inc.
 Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Direktor/Vorstandsmitglied | 01.03.2018 | - |
| Vorstandsvorsitzender | 01.03.2018 | - |
Karriereverlauf von M. Scott Salka
Ehemalige bekannte Positionen von M. Scott Salka
| Unternehmen | Position | Beginn | Ende |
|---|---|---|---|
MorphImmune, Inc.
 MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Vorstandsvorsitzender | 01.05.2020 | 12.04.2021 |
AmpliPhi Biosciences Corp.
 AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Direktor/Vorstandsmitglied | 18.05.2015 | 31.05.2017 |
| Vorstandsvorsitzender | 18.05.2015 | 31.05.2017 | |
Rakuten Medical, Inc.
 Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Vorstandsvorsitzender | 01.03.2010 | 01.05.2015 |
| Gründer | 01.03.2010 | 01.05.2015 | |
| ░░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░░░ ░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░ | ░░░░░░░░░░ | ░░░░░░░░░░ | |
| ░░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░░░░░░░░░ ░░░░░░░ | - | ░░░░░░░░░░ |
| ░░░░░░░░ ░░ ░░░░░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░ | - | ░░░░░░░░░░ | |
| ░░░░░░░░ ░░░░ | ░░░░░░░░░ | - | - |
| ░░░ ░░░░ ░░░░░░░░ ░░░░░ | ░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░ ░░░░░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░ ░░░░░░░░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░░░░░ ░░░░░░░░░ ░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
| ░░░░░░ ░░░░░ ░ ░░░ ░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von M. Scott Salka
| Carnegie Mellon University | Masters Business Admin |
| San Diego State University | Undergraduate Degree |
Statistik
International
| Vereinigte Staaten | 20 |
| Deutschland | 2 |
Operativ
| Chief Executive Officer | 7 |
| Director/Board Member | 6 |
| Corporate Officer/Principal | 5 |
Sektoral
| Health Technology | 7 |
| Commercial Services | 6 |
| Consumer Services | 4 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
| Börsennotierte Unternehmen | 2 |
|---|---|
| UNISYS CORPORATION | Technology Services |
| SORRENTO THERAPEUTICS, INC. | Health Technology |
| Private Unternehmen | 15 |
|---|---|
Goodrich Corp.
 Goodrich Corp. Aerospace & DefenseElectronic Technology Goodrich Corp. engages in the supply of systems and services to the aerospace, defense and homeland security markets. The company was founded by Benjamin Franklin Goodrich in 1870 and is headquartered in Charlotte, NC. | Electronic Technology |
AmpliPhi Biosciences Corp.
AmpliPhi Biosciences Corp. BiotechnologyHealth Technology AmpliPhi Biosciences Corp. clinical-stage biotechnology company, which engages in the discovery, development, and commercialization of therapies for antibiotic-resistant infections using bacteriophage-based technology. Its products include AB-SA01 and AB-PA01, which targets staphylococcus aureus and pseudomonas aeruginosa. The company was founded in March 1989 and is headquartered in San Diego, CA. | Health Technology |
Sequana Therapeutics, Inc.
 Sequana Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Sequana Therapeutics Inc. is a leading genomics company that uses industrial-scale gene-finding technologies and functional genomics to develop products aimed at diagnosing and treating common human diseases | Commercial Services |
Ambit Biosciences Corp.
 Ambit Biosciences Corp. Pharmaceuticals: MajorHealth Technology Ambit Biosciences Corp. develops pharmaceutical drugs. It engages in discovery, development and commercialization of small-molecule kinase inhibitors for the treatment of cancer. The firm provides drug to treat unmet medical needs in oncology, autoimmune and inflammatory diseases. The company was founded on May 17, 2000 and is headquartered in San Diego, CA. | Health Technology |
Arcaris, Inc.
 Arcaris, Inc. Miscellaneous Commercial ServicesCommercial Services Arcaris, Inc. develops genetic, proteomic, and cell biological systems for direct identification and validation of novel drug targets. The company is headquartered in Salt Lake City, UT. | Commercial Services |
Roche Diagnostics GmbH
 Roche Diagnostics GmbH Miscellaneous Commercial ServicesCommercial Services Part of Roche Holding AG, Roche Diagnostics GmbH is a German company that develops innovative medicines, treatments, and diagnostics. The company is based in Mannheim, Germany. The CEOs of the company are Claudia Fleischer, Claus Haberda, Clemens Schmid. Roche Diagnostics was acquired by Roche Holding AG on January 01, 1999. | Commercial Services |
454 Life Sciences Corp.
 454 Life Sciences Corp. Medical/Nursing ServicesHealth Services 454 Life Sciences Corp. engages in the provision of medical testing services to determine the nucleotide sequence of whole genomes. The company was founded by Jonathan M. Rothberg in 2000 and is headquartered in Branford, CT. | Health Services |
BIOCOM
BIOCOM Miscellaneous Commercial ServicesCommercial Services BIOCOM provides scientific and technological services. The firm focuses that positively influence the growth of the life science industry, including capital formation, public policy, workforce development and scientific discovery and development. The company was founded in 1995 and is headquartered in San Diego, CA. | Commercial Services |
Boehringer Ingelheim Corp.
 Boehringer Ingelheim Corp. Pharmaceuticals: MajorHealth Technology Boehringer Ingelheim Corp. develops, manufactures and markets health care products. It focuses in the therapeutic areas of cardiovascular disease, respiratory diseases, diseases of the central nervous system, metabolic diseases, virological diseases and oncology. The company was founded on December 8, 1986 and is headquartered in Ridgefield, CT. | Health Technology |
| Parke, Davis & Co. LLC | |
| Vesper Biologics, Inc. | |
| CendR, Inc. | |
Arog Pharmaceuticals, Inc.
Arog Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Arog Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company that focuses on the discovery, development and commercialization of drugs to treat unmet medical needs in oncology. It offers clinical trials for Acute Myeloid Leukemia, Gastrointestinal Stromal Tumor, and Glioma. The company was founded by Vinay K. Jain in 2010 and is headquartered in Dallas, TX. | Health Technology |
Rakuten Medical, Inc.
Rakuten Medical, Inc. Miscellaneous Commercial ServicesCommercial Services Rakuten Medical, Inc. operates as a clinical stage biotechnology company which develops tumor-targeted precision therapies. It develops new anticancer therapies based on the photoimmunotherapy platform. The company was founded in 2010 and is headquartered in San Diego, CA. | Commercial Services |
MorphImmune, Inc.
MorphImmune, Inc. BiotechnologyHealth Technology MorphImmune, Inc. is a biotechnology company that specializes in developing targeted oncology therapeutics. MorphImmune is based in West Lafayette, IN and has been led by CEO Clay B. Siegall since 2023. The company's proprietary targeted effector platform delivers payloads to diseased cells, reducing toxicity and increasing efficacy of known effector molecules. The company was founded on the research of Philip S. Low, Ph.D., the Presidential Scholar for Drug Discovery and Ralph C. Corley Distinguished Professor of Chemistry at Purdue University. | Health Technology |
- Börse
- Insiders
- M. Scott Salka
- Erfahrung
